<DOC>
	<DOCNO>NCT01417936</DOCNO>
	<brief_summary>The trial design multi-center , open label Phase 2 trial investigates efficacy safety Sym004 subject squamous cell cancer head neck ( SCCHN ) . Subjects include must respond previous anti-epidermal growth factor receptor ( anti-EGFR ) monoclonal antibody-based therapy subsequently become resistant therapy . It believe Sym004 potential induce tumor response provide superior treatment option subject advance SCCHN . Symphogen sponsor planning/conducting report result trial .</brief_summary>
	<brief_title>Sym004 SCCHN Patients Failing Anti-EGFR Based Therapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Histologically confirm diagnosis initially relapse SCCHN oral cavity , oropharynx , hypopharynx larynx Recurrent and/or metastatic SCCHN amenable curative treatment surgery and/or ( chemo ) radiation Previous treatment antiEGFR monoclonal antibody ( mAb ) palliative set either monotherapy combination chemotherapy radiotherapy showing : Documented clinical benefit response least 8 week ( PR , CR SD ) antiEGFR mAbbased therapy Documented disease progression ( verify compute tomography [ CT ] scan magnetic resonance image [ MRI ] accord RECIST ( 1.1 ) within 12 week follow last administration antiEGFR mAb Accessible tumor biopsy subject acceptance repeat tumor biopsies Other protocoldefined inclusion criterion could apply More 2 line prior chemotherapy palliative setting Expected survival &lt; 12 week Subjects know brain metastasis Chemotherapy radiation therapy within 21 day prior Visit 2 exception palliative radiotherapy bleed pain , allow anytime , give target lesion AntiEGFR mAbs within 14 day prior Visit 2 Major surgery within 4 week prior Visit 2 subject must recover effect major surgery Other protocoldefined exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>